IM Cannabis Business Summary

IM Cannabis Corp. (IMCC) operates as a specialized international medical cannabis provider, generating revenue through the transactional sale of premium medical cannabis products and fulfillment services. The company’s business is bifurcated into two primary geographic segments: Israel and Germany. In Israel, the company maintains a vertically integrated presence through its relationship with Focus Medical Herbs Ltd., encompassing cultivation, import, and a retail ecosystem of pharmacies and online delivery platforms. In Germany, operations are centered on Adjupharm GmbH, which utilizes an EU-GMP certified production facility and a GDP-compliant logistics center to distribute products to pharmacies and provide third-party fulfillment services. Positioned as a lean, medical-focused operator, IMCC recently exited the Canadian adult-use market to concentrate resources on high-margin regulatory environments, competing directly with global giants such as Aurora Cannabis, Canopy Growth, Tilray Brands, and Bedrocan International by maintaining a more concentrated footprint in the Israeli and European medical sectors. The company was co-founded by CEO Oren Shuster and Rafael Gabay, both of whom bring extensive entrepreneurial backgrounds from the technology and med-tech sectors, notably as founders of the global software firm E-wave Group. Shuster, a prominent figure in the Israeli cannabis industry for over a decade, leads the executive team alongside Chief Financial Officer Asi Levi, a CPA appointed in December 2025 with over 15 years of experience in international finance and previous CFO roles at Water Ways Technologies and DekelOil CI. The leadership team is further supported by Richard Balla, CEO of German Operations, and Yael Harrosh, Chief Legal and Operations Officer. Notable board members include Alon Dayan, CEO of KeepZone AI, and Oz Adler, CEO of SciSparc Ltd., reflecting a leadership pedigree rooted in highly regulated technology and pharmaceutical industries.